Primary Peritoneal Carcinoma Completed Phase 1 Trials for Bevacizumab (DB00112)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02217956Dose Escalation of Cisplatin Hyperthermic Intraperitoneal Chemotherapy After Surgery in Patients With Unresectable Stage IIIC Ovarian, Tube or Peritoneal Primary AdenocarcinomaTreatment